- Raised $1.1M PIPE, Feb 2026
- Raised $550k Seed round, Jul 2022
- Raised $1.5M Pre-Seed round, Nov 2020
About
PsyRx is an Israeli biopharma company developing innovative combination drugs to address mental health challenges, particularly treatment-resistant depression. Their technology focuses on combining existing SSRI antidepressants with micro-doses of psychoactive substances like ibogaine and psilocybin, aiming for faster therapeutic onset, improved response, and reduced side effects without causing a psychedelic experience. The company also produces pharmaceutical-grade active compounds from natural sources using a proprietary agro-medical bioreactor platform. PsyRX CNS Bio-Tech Ltd, formerly Cannabotech LTD, engages in developing cannabinoid-based medication and healthcare products, including personalized cannabinoid-based products and CBD-based skincare and food-supplement products.
Funding history · 5 rounds · $3.1M total
Headcount over time
Q&A
- What is PsyRx's primary focus in drug development?
- PsyRx is a pharmaceutical R&D company focused on developing biological API psilocybin and ibogaine using biological bioreactor technology, aiming to become a leading producer of GMP-standard versions of these compounds.
- What is PsyRx's vision for a new antidepressant drug?
- PsyRx aims to develop a revolutionary antidepressant drug that combines ibogaine with existing approved antidepressants, with the goal of reducing side effects and improving efficacy for the treatment of depression and addiction.
- When was PsyRx founded?
- PsyRx was founded in October 2019.
- What is the total amount of funding PsyRx has raised to date?
- PsyRx has raised a total of $2,380,000 USD.
- When was PsyRx's most recent funding round?
- PsyRx's most recent funding round occurred in July 2023, raising $330,000 USD.
- Who are the co-founders of PsyRx?
- The co-founders of PsyRx include Asher Holzer, Itay Hecht, and Kobi Buxdorf.
- What is PsyRx's current product stage?
- PsyRx's product is currently in the clinical trial stage.
Team · 3
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | psyrx.co/ |
|---|---|
| linkedin.com/company/79826212 | |
| facebook.com/psyrxpsychedelics |
Identifiers & details
| Legal name | PsyRX CNS Bio-Tech Ltd |
|---|---|
| Founded | 2019 |
| Employees (exact) | 7 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | psyrx.co |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516095668 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-10-23 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 1 |
| Registry events | 4 — shares_capital (1), annual_report (1), charge (1), people (1) |
| Registered address | ז'בוטינסקי 31 חולון |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-27 | העברת מניות |
| 2025-09-25 | דו~ח שנתי |
| 2025-08-05 | רישום שעבוד |
| 2026-03-01 | עדכון דירקטורים-הסרת דירקטור |